Lovely Day Foods

Berlin, Germany

Lovely Day Foods is a food biotech company creating bio-identical proteins to use as animal-free replacers in food, beverages and more.

$1.2M raised

Mar 2022

Pre-Seed

Biotechnology Food and Beverage Food Processing

Top Investors

Stray Dog Capital Foodspring JustSpices Sustainable Food Ventures e squared

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lovely Day Foods

How much funding has Lovely Day Foods raised?

Lovely Day Foods has raised $1.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2022.

Who are Lovely Day Foods's investors?

Lovely Day Foods's investors include Stray Dog Capital, Foodspring, JustSpices, Sustainable Food Ventures, e squared.

Where is Lovely Day Foods headquartered?

Lovely Day Foods is headquartered in Berlin, Germany.

What does Lovely Day Foods do?

Lovely Day Foods is a food biotech company creating bio-identical proteins to use as animal-free replacers in food, beverages and more.

What stage is Lovely Day Foods at?

Lovely Day Foods is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 10, 2022.

MLA

"Lovely Day Foods — Funding & Investors." VCBacked, March 10, 2022, https://www.vcbacked.co/company/lovely-day-foods. Accessed July 3, 2026.

APA

VCBacked. (2022). Lovely Day Foods — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/lovely-day-foods

Wikipedia (cite web)

{{cite web |title=Lovely Day Foods — Funding & Investors |url=https://www.vcbacked.co/company/lovely-day-foods |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 10, 2022.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K